Exposure to cadmium (Cd) as a result of its environmental pervasiveness poses deleterious health effects, which has been attributed to oxidative stress. Therefore, this study aims to examine the sub-acute (1 mg Cd/kg/day, i.p., for 3 weeks) systemic and thrombotic influence of Cd exposure in vivo, and to assess the protective effects of the antioxidant L-2-Oxothiazolidine-4-Carboxylic acid (OTC, 80 mg/kg/day, i.p.). Cd compared with control group significantly reduced both the time for the first platelet aggregate and until blood flow stopped in pial microvessels. OTC significantly increased both the time for the first aggregate and until flow stopped. Cd induced a significant increase in total WBC, CK, AST, and LDH. The antioxidants SOD and catalase activities significantly increased in mice treated with Cd. OTC, through its antioxidant actions, appeared to effectively protect Cd induced thrombosis in mice. Hence, OTC represents a potential protective candidate from the detrimental effect of Cd toxicity.
|Number of pages||8|
|Journal||International Journal of Clinical and Experimental Medicine|
|Publication status||Published - Aug 30 2016|
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)